Riskpilot← Back to searchSign inGet full accessMEDIBRIX AS
ASActiveOrg 912540863Sjøgata 5, 9405 HarstadComputer programming activities · NACE 6210Est. 201312 employeesmedibrix.com
Revenue 2024
NOK 28,6M
+4% vs 2023
EBITDA margin
4.5%
+124% vs 2023
Equity ratio
53.5%
Financial strength
Net profit 2024
NOK -13,4M
+29% vs 2023
| Revenue | NOK 28,6M | +4% |
| EBITDA | NOK 1,3M | +124% |
| Net profit | NOK -13,4M | +29% |
| Total assets | NOK 58,9M | +3% |
| Equity | NOK 31,5M | -29% |
| Employees | 12 | — |
Legal name
MEDIBRIX AS
Org number
912540863
Legal form
Aksjeselskap
NACE code
6210 · Computer programming activities
Founded
5. oktober 2013
Share capital
NOK 1 691 250
Employees
12 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Selskapet skal utvikle og formidle helserelatert programvare, tjenester og relatert utstyr til privatpersoner, organisasjoner og helsepersonell for å bidra til bedret folkehelse og egenomsorg samt støtte til helsepersonell.
Address
Sjøgata 5, 9405 Harstad
Phone
+4777060101
Email
kontakt@helseboka.no
Website
medibrix.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 96 | 151 | 330 | 278 | 100 | 568 | 3 607 | 120 029 | 49 600 | 27 447 | 28 615 |
| Staff expenses | −0 | −3 | −1 | −0 | −0 | −681 | −1 134 | −898 | −15 480 | −18 907 | −17 695 | −12 790 |
| EBITDA | −21 | −29 | −362 | −293 | −535 | −1 188 | −1 320 | −1 441 | 65 155 | 6 365 | −5 413 | 1 282 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −4 | −9 | −1 665 | −3 528 | −7 745 | −19 009 | −17 473 |
| EBIT | −21 | −29 | −362 | −293 | −535 | −1 191 | −1 328 | −3 105 | 61 626 | −1 380 | −24 422 | −16 192 |
| Net financials | 0 | 3 | −2 | 1 | −8 | −0 | −14 | −18 | −180 | −97 | 228 | −982 |
| Profit before tax | −21 | −26 | −364 | −292 | −543 | −1 192 | −1 342 | −3 124 | 61 446 | −1 477 | −24 194 | −17 173 |
| Tax | −0 | −29 | −34 | −47 | −52 | −0 | −0 | −0 | 10 336 | −315 | −5 323 | −3 769 |
| Net profit | −21 | 3 | −330 | −245 | −491 | −1 192 | −1 342 | −3 124 | 51 110 | −1 162 | −18 871 | −13 404 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 14 | 423 | 193 | 115 | 283 | 6 222 | 6 233 | 9 029 | 97 254 | 77 789 | 57 036 | 58 893 |
| Equity | 9 | 387 | 14 | −88 | −32 | 5 070 | 5 728 | 4 604 | 64 774 | 64 183 | 44 277 | 31 537 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 53 | 53 | 3 206 | 53 | 53 | 21 270 |
| Short-term debt | 4 | 36 | 178 | 202 | 314 | 1 151 | 452 | 4 372 | 29 274 | 13 553 | 12 706 | 6 087 |
| Total debt | 4 | 36 | 178 | 202 | 314 | 1 151 | 505 | 4 425 | 32 480 | 13 606 | 12 759 | 27 356 |
EBITDA margin
4.5%
This company
15.8%
Market median
-72% vs market
20132024
Equity ratio
53.5%
This company
38.2%
Market median
+40% vs market
20132024
Return on equity
-42.5%
This company
18.4%
Market median
-331% vs market
20132024
Net profit margin
-46.8%
This company
8.1%
Market median
-678% vs market
20132024
Asset turnover
0.49×
This company
1.12×
Market median
-56% vs market
20132024
Debt / equity
0.87×
This company
0.62×
Market median
+40% vs market
20132024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ET Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
MC Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2026 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Helseboka Holding As | Company | 99.3% | 99.3% | 2024 |
Fürst Holding As | Company | 57.5% | 57.5% | 2022 |
Precuro As | Company | 32.1% | 32.1% | 2022 |
| Individual | 9.4% | 9.4% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Precuro As
MEDIBRIX AS Board members of MEDIBRIX AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Trondsen | Chief Executive Officer | 0 companies |
| Marius Christensen | Chief Executive Officer | 0 companies |
| Maria Syse-Nybraaten | Board of Directors | 0 companies |
| Lars Halvor Sund Langmoen | Chairman | 0 companies |
| Anders Kristian Stormo | Board of Directors | 0 companies |
| Ivar Andre Simonsen | Chairman | 0 companies |
| Ivar Kroghrud | Chairman | 0 companies |
| Hans Jakob Collett Humlevik | Board of Directors | 0 companies |
| Benedicte Elisabeth Bakke Agerup | Board of Directors | 0 companies |